Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SMN1 Antibody (R2H29)

Catalog #:   RHH32804 Specific References (46) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, IP, WB
Accession: Q16637
Overview

Catalog No.

RHH32804

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

SMNC, Survival motor neuron protein, SMNT, Component of gems 1, SMN1, SMN, Gemin-1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q16637

Applications

IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2H29

Data Image
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human lung cancer using Gemin 1 antibody.High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of SMN/Gemin 1 in Hela lysates using SMN antibody.
References

Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns., PMID:38781723

Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project., PMID:37606479

Advances and limitations for the treatment of spinal muscular atrophy., PMID:36329412

Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy., PMID:35943879

Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies., PMID:35302338

[Pharmacological and clinical profile of Onasemnogene Aveparvovec, the first gene therapy for spinal muscular atrophy (SMA)]., PMID:34980814

Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)., PMID:34360794

Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy., PMID:34196026

Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy., PMID:30481286

Carbon nanofiber-based multiplexed immunosensor for the detection of survival motor neuron 1, cystic fibrosis transmembrane conductance regulator and Duchenne Muscular Dystrophy proteins., PMID:29890394

Electrochemical immunosensors for the detection of survival motor neuron (SMN) protein using different carbon nanomaterials-modified electrodes., PMID:29096367

Cellular bases of the RNA metabolism dysfunction in motor neurons of a murine model of spinal muscular atrophy: Role of Cajal bodies and the nucleolus., PMID:28823932

A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein., PMID:27481219

Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy., PMID:26321202

Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy., PMID:25514431

KGF and BMP-6 intervene in cellular reprogramming and in mesenchymal-epithelial transition (MET) of 3T3L1 mouse adipose cells., PMID:25492426

Spinal muscular atrophy pathogenic mutations impair the axonogenic properties of axonal-survival of motor neuron., PMID:22324632

Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders., PMID:22083460

Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient., PMID:21956898

Double trouble: spinal muscular atrophy type II and seropositive myasthenia gravis in the same patient., PMID:21862330

Proteomic assessment of a cell model of spinal muscular atrophy., PMID:21385431

HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects., PMID:21088113

Abnormal interaction of motor neuropathy-associated mutant HspB8 (Hsp22) forms with the RNA helicase Ddx20 (gemin3)., PMID:20157854

HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1., PMID:19628962

Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy., PMID:18771690

Neurodevelopmental abnormalities in neurosphere-derived neural stem cells from SMN-depleted mice., PMID:18521935

[An experimental research on differentiation of mesenchymal stem cells derived from children with spinal muscular atrophy into neuron-like cells]., PMID:17937857

Refined characterization of the expression and stability of the SMN gene products., PMID:17717146

Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts., PMID:16951947

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells., PMID:16724231

A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels., PMID:15790598

Monitoring of recombinant survival motor neuron protein using fiber-optic surface plasmon resonance., PMID:15343403

A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons., PMID:14644474

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy., PMID:12915451

Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells., PMID:12783893

Survival motor neuron protein in the nucleolus of mammalian neurons., PMID:12126878

A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy., PMID:11978761

Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein., PMID:11641277

Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype., PMID:11313744

Expression and subcellular localization of two isoforms of the survival motor neuron protein in different cell types., PMID:11054803

Excitatory amino acid stimulation of the survival of rat cerebellar granule cells in culture is associated with an increase in SMN, the spinal muscular atrophy disease gene product., PMID:10901626

Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord., PMID:10587577

SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis., PMID:10234506

Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport., PMID:9987032

Survival motor neuron (SMN) protein in rat is expressed as different molecular forms and is developmentally regulated., PMID:9758161

Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system., PMID:9302277

Datasheet

Document Download

Anti-SMN1 Antibody (R2H29).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SMN1 Antibody (R2H29) [RHH32804]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only